Sergey Orlov
Impact in
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Oncology top 5%
- Lung Cancer Research Studies
- Colorectal Cancer Treatments and Studies
Papers in
-
- Lung Cancer Treatments and Mutations 60
- Lung Cancer Diagnosis and Treatment 22
- Oncology 57
- Lung Cancer Research Studies 30
- Colorectal Cancer Treatments and Studies 14
- Cancer Immunotherapy and Biomarkers 8
- Co-authors
- Dizhe Eb (31 shared papers)Perevozchikov Ap (25 shared papers)Vladimir S. Shavva (25 shared papers)Denis A. Mogilenko (18 shared papers)Wu‐Chou Su (11 shared papers)Lecia V. Sequist (11 shared papers)James Chih‐Hsin Yang (9 shared papers)S. V. Burov (5 shared papers)
- Journals
- Journal of Clinical Oncology (27 papers)Annals of Oncology (24 papers)Journal of Thoracic Oncology (12 papers)Journal of Biological Chemistry (3 papers)Cancer Research (2 papers)
- Partner nations
- RussiaUnited StatesSouth Korea
In The Last Decade
Sergey Orlov
144 papers receiving 2.0k citations
Sergey Orlov's Hit Papers
Peers
Comparison fields: 5 of 99
- Pulmonary and Respiratory Medicine 984
- Oncology 690
- Cancer Research 258
- Hepatology 99
- Molecular Biology 744
Countries citing papers authored by Sergey Orlov
This map shows the geographic impact of Sergey Orlov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sergey Orlov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sergey Orlov more than expected).
Fields of papers citing papers by Sergey Orlov
This network shows the impact of papers produced by Sergey Orlov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sergey Orlov. The network helps show where Sergey Orlov may publish in the future.
Co-authors
The 25 scholars most cited alongside Sergey Orlov, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 150 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Osimertinib plus savolitinib in patients with EGFR mutation-positive, MET-amplified, non-small-cell lung cancer after progression on EGFR tyrosine kinase inhibitors: interim results from a multicentre, open-label, phase 1b study Hit paper breakdown → | 2020 | 306 |
| 2 | 2003 | 178 | |
| 3 | 2012 | 139 | |
| 4 | 2019 | 85 | |
| 5 | 2018 | 75 | |
| 6 | 2015 | 70 | |
| 7 | 2009 | 63 | |
| 8 | 1993 | 59 | |
| 9 | 2012 | 55 | |
| 10 | 2011 | 52 | |
| 11 | 2012 | 45 | |
| 12 | 2012 | 40 | |
| 13 | 2014 | 39 | |
| 14 | 2023 | 34 | |
| 15 | 2010 | 34 | |
| 16 | 2019 | 32 | |
| 17 | 2019 | 30 | |
| 18 | 2018 | 27 | |
| 19 | 2013 | 23 | |
| 20 | 2013 | 22 |
About Sergey Orlov
Sergey Orlov is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Surgery and Epidemiology, having authored 150 papers that have together received 2.1k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (60 papers), Lung Cancer Research Studies (30 papers), Lung Cancer Diagnosis and Treatment (22 papers), Peroxisome Proliferator-Activated Receptors (16 papers), Colorectal Cancer Treatments and Studies (14 papers), Cholesterol and Lipid Metabolism (10 papers), Cancer, Lipids, and Metabolism (9 papers) and Cancer Immunotherapy and Biomarkers (8 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (984 citations), Oncology (690 citations), Cancer Research (258 citations), Hepatology (99 citations) and Molecular Biology (744 citations). Sergey Orlov has collaborated with scholars based in Russia, United States and South Korea. Frequent co-authors include Dizhe Eb, Perevozchikov Ap, Vladimir S. Shavva, Denis A. Mogilenko, Wu‐Chou Su, Lecia V. Sequist, James Chih‐Hsin Yang, S. V. Burov, Ji‐Youn Han and Anders Mellemgaard. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Journal of Thoracic Oncology, Journal of Biological Chemistry and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.